[1] 叶定伟, 朱耀. 中国前列腺癌的流行病学概述和启示[J]. 中华外科杂志, 2015, 53(4):249-252.
[2] 孙颖浩. 我国前列腺癌的研究现状[J]. 中华泌尿外科杂志, 2004, 25(2):77-80.
[3] 刘适. 血清TPSA、FPSA及FPS/TPSA在前列腺癌诊断中的应用价值[J]. 实用预防医学, 2011, 18(3):523-524.
[4] 姚小刚, 朱培菊, 赵明, 等. DCE-MRI参数对比改良Gleason评分、PSA预测前列腺癌患者治疗后去势抵抗性前列腺癌的风险性[J]. 中国临床医学影像杂志, 2018, 29(11):803- 807.
[5] Zhao L, Wang D, Shi G, et al. Dual-labeled chemiluminescence enzyme immunoassay for simultaneous measurement of total prostate specific antigen (TPSA) and free prostate speci-fic antigen (FPSA)[J]. Luminescence, 2017, 32(8):1547-1553.
[6] Taghipour M, Ziaei A, Alessandrino F, et al. Investigating the role of DCE-MRI, over T2 and DWI, in accurate PI-RADS v2 assessment of clinically significant peripheral zone prostate lesions as defined at radical prostatectomy[J]. Abdominal Radiology, 2019, 44(4):1520-1527.
[7] Cristel G, Esposito A, Briganti A, et al. MpMRI of the prostate:is there a role for semi-quantitative analysis of DCE-MRI and late gadolinium enhancement in the characterisation of prostate cancer?[J]. Journal of Clinical Radiology, 2019, 74(4):259-267.
[8] Yang J, Tang A, Zhang S, et al. The age-specific reference intervals for tPSA, fPSA, and%fPSA in healthy Han ethnic male[J]. Journal of Clinical Laboratory Analysis, 2017, 31(4):22062-22066.
[9] 张永胜, 龚向阳, 陈瑶, 等. 基于PI-RADS研究MRI多参数成像对移行区前列腺癌的诊断价值[J]. 临床放射学杂志, 2015, 34(6):930-934.
[10] Chatterjee A, He D, Fan X, et al. Performance of ultrafast DCE-MRI for diagnosis of prostate cancer[J]. Academic Radiology, 2018, 25(3):349-358.
[11] 平小夏, 王希明, 孟倩, 等. 3.0T DCE-MRI在前列腺癌诊断中的应用价值[J]. 实用放射学杂志, 2017, 33(2):244-247.
[12] Bane O, Hectors S J, Wagner M, et al. Accuracy, repeatability, and interplatform reproducibility of T1 quantification methods used for DCE-MRI:Results from a multicenter phantom study[J]. Magnetic Resonance in Medicine, 2018, 79(5):2564-2575.
[13] Ma X Z, Lyu K, Sheng J L, et al. Application evaluation of DCE-MRI combined with quantitative analysis of DWI for the diagnosis of prostate cancer[J]. Oncology Letters, 2019, 17(3):3077-3084.
[14] 陈钇地, 龙莉玲, 彭鹏, 等. DCE-MRI定量参数与前列腺癌Gleason评分及血清PSA相关性分析的价值[J]. 临床放射学杂志, 2018, 37(10):1693-1697.
[15] 付敏, 杨宗桥, 莫远梅, 等. 血清tPSA、fPSA及fPSA/tPSA比值联合检测在前列腺疾病诊断中的临床应用[J]. 中国地方病防治杂志, 2014, 29(1):128-128.
[16] 王志粉, 王书中, 杨士军, 等. 探讨血清tPSA、fPSA及其比值在淮安地区进行前列腺疾病筛查以及前列腺癌鉴别的合理运用[J]. 标记免疫分析与临床, 2018, 25(3):329-332.
[17] 张红侠, 贾健安, 芮兵. 急性前列腺炎血清tPSA、fPSA、fPSA/tPSA检测及其临床诊断价值分析[J]. 中国医学前沿杂志(电子版), 2018, 10(6):179-181. |